Browsing by Author HO HAN KIAT

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Showing results 25 to 32 of 32 < previous 
Issue DateTitleAuthor(s)
Sep-2013Nanomaterial scaffolds for stem cell proliferation and differentiation in tissue engineeringZhao, C.; Tan, A.; Pastorin, G. ; Ho, H.K. 
2015Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's diseaseHuleatt Paul B.; Khoo Mui Ling; Chua Yi Yuan; Tan Tiong Wei; Liew Rou Shen; Balogh Balazs; Deme Ruth; Goloncser Flora; Magyar Kalman; Sheela David P.; HO HAN KIAT ; Sperlagh Beta; Matyus Peter; Chai Li Lin Christina 
Mar-2002Public Awareness of Diabetes Mellitus in SingaporeWee, H.L. ; Ho, H.K. ; Li, S.C. 
15-Dec-2012Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer propertiesSaha, S.; Chan, D.S.Z.; Lee, C.Y.; Wong, W.; New, L.S. ; Chui, W.K. ; Yap, C.W. ; Chan, E.C.Y. ; Ho, H.K. 
30-Oct-2011Reversible time-dependent inhibition of cytochrome P450 enzymes by duloxetine and inertness of its thiophene ring towards bioactivationChan, C.Y.; New, L.S. ; Ho, H.K. ; Chan, E.C.Y. 
Apr-2013Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysisTeo, Y.L.; Ho, H.K. ; Chan, A. 
28-Dec-2010Thin films of functionalized multiwalled carbon nanotubes as suitable scaffold materials for stem cells proliferation and bone formationNayak, T.R.; Jian, L. ; Phua, L.C.; Ho, H.K. ; Ren, Y.; Pastorin, G. 
Jan-2014Vascular endothelial growth factor inhibitors and cognitive impairment: Evidence and controversiesNg, T.; Cheung, Y.T.; Ng, Q.S.; Ho, H.K. ; Chan, A.